Yen Ying Lim1, Simon M Laws2, Victor L Villemagne2, Robert H Pietrzak2, Tenielle Porter2, David Ames2, Christopher Fowler2, Stephanie Rainey-Smith2, Peter J Snyder2, Ralph N Martins2, Olivier Salvado2, Pierrick Bourgeat2, Christopher C Rowe2, Colin L Masters2, Paul Maruff2. 1. From The Florey Institute of Neuroscience and Mental Health (Y.Y.L., V.L.V., C.F., C.L.M., P.M.), The University of Melbourne, Parkville; Centre of Excellence for Alzheimer's Disease Research and Care (S.M.L., T.P., S.R.-S., R.N.M.), Edith Cowan University, Joondalup, Australia; Department of Psychiatry (R.H.P.), Yale University School of Medicine, New Haven, CT; Academic Unit for Psychiatry of Old Age (D.A.), St. Vincent's Health, The University of Melbourne, Kew; National Ageing Research Institute (D.A.), Parkville, Australia; Department of Neurology (P.J.S.), Warren Alpert Medical School of Brown University, Providence, RI; Commonwealth Scientific Industrial Research Organization (CSIRO) Preventative Health National Research Flagship (O.S., P.B.), Australian e-Health Research Centre-BiaMedIA, Brisbane; Departments of Nuclear Medicine and Centre for PET (V.L.V., C.C.R.) and Medicine (V.L.V., C.C.R.), Austin Health, Heidelberg; Sir James McCusker Alzheimer's Disease Research Unit (S.M.L., T.P.), Hollywood Private Hospital, Perth; Co-operative Research Centre for Mental Health (S.M.L., T.P.), Carlton South; and CogState Ltd. (P.M.), Melbourne, Australia. yen.lim@florey.edu.au. 2. From The Florey Institute of Neuroscience and Mental Health (Y.Y.L., V.L.V., C.F., C.L.M., P.M.), The University of Melbourne, Parkville; Centre of Excellence for Alzheimer's Disease Research and Care (S.M.L., T.P., S.R.-S., R.N.M.), Edith Cowan University, Joondalup, Australia; Department of Psychiatry (R.H.P.), Yale University School of Medicine, New Haven, CT; Academic Unit for Psychiatry of Old Age (D.A.), St. Vincent's Health, The University of Melbourne, Kew; National Ageing Research Institute (D.A.), Parkville, Australia; Department of Neurology (P.J.S.), Warren Alpert Medical School of Brown University, Providence, RI; Commonwealth Scientific Industrial Research Organization (CSIRO) Preventative Health National Research Flagship (O.S., P.B.), Australian e-Health Research Centre-BiaMedIA, Brisbane; Departments of Nuclear Medicine and Centre for PET (V.L.V., C.C.R.) and Medicine (V.L.V., C.C.R.), Austin Health, Heidelberg; Sir James McCusker Alzheimer's Disease Research Unit (S.M.L., T.P.), Hollywood Private Hospital, Perth; Co-operative Research Centre for Mental Health (S.M.L., T.P.), Carlton South; and CogState Ltd. (P.M.), Melbourne, Australia.
Abstract
OBJECTIVE: As the absence of Aβ-related memory decline in APOE ε4 noncarriers may be due to the relative brevity of previous studies, we aimed to characterize Aβ-related cognitive decline over 72 months in APOE ε4 carriers and noncarriers who were cognitively normal (CN). METHODS: CN older adults (n = 423) underwent Aβ imaging and APOE genotyping. Participants completed comprehensive neuropsychological testing at baseline 18-, 36-, 54-, and 72-month assessments. RESULTS: Relative to Aβ- CN ε4 noncarriers, both Aβ+ CN ε4 carriers and noncarriers showed significantly increased decline in measures of memory, language, and executive function as well as higher rates of progression to a clinical classification of mild cognitive impairment. Memory decline was greater in Aβ+ CN ε4 carriers than in Aβ+ CN ε4 noncarriers. No cognitive decline was evident in Aβ- CN ε4 carriers. CONCLUSIONS: In CN older adults, Aβ+ is associated with memory decline in ε4 noncarriers; however, the rate of this decline is much slower than that observed in ε4 carriers. These data indicate that the processes by which ε4 carriage increases the rate of Aβ-related cognitive decline occur in the preclinical stage of Alzheimer disease.
OBJECTIVE: As the absence of Aβ-related memory decline in APOE ε4 noncarriers may be due to the relative brevity of previous studies, we aimed to characterize Aβ-related cognitive decline over 72 months in APOE ε4 carriers and noncarriers who were cognitively normal (CN). METHODS: CN older adults (n = 423) underwent Aβ imaging and APOE genotyping. Participants completed comprehensive neuropsychological testing at baseline 18-, 36-, 54-, and 72-month assessments. RESULTS: Relative to Aβ- CN ε4 noncarriers, both Aβ+ CN ε4 carriers and noncarriers showed significantly increased decline in measures of memory, language, and executive function as well as higher rates of progression to a clinical classification of mild cognitive impairment. Memory decline was greater in Aβ+ CN ε4 carriers than in Aβ+ CN ε4 noncarriers. No cognitive decline was evident in Aβ- CN ε4 carriers. CONCLUSIONS: In CN older adults, Aβ+ is associated with memory decline in ε4 noncarriers; however, the rate of this decline is much slower than that observed in ε4 carriers. These data indicate that the processes by which ε4 carriage increases the rate of Aβ-related cognitive decline occur in the preclinical stage of Alzheimer disease.
Authors: Yen Ying Lim; Pawel Kalinowski; Robert H Pietrzak; Simon M Laws; Samantha C Burnham; David Ames; Victor L Villemagne; Christopher J Fowler; Stephanie R Rainey-Smith; Ralph N Martins; Christopher C Rowe; Colin L Masters; Paul T Maruff Journal: JAMA Neurol Date: 2018-04-01 Impact factor: 18.302
Authors: Kirsty Lu; Jennifer M Nicholas; Yoni Pertzov; John Grogan; Masud Husain; Ivanna M Pavisic; Sarah-Naomi James; Thomas D Parker; Christopher A Lane; Ashvini Keshavan; Sarah E Keuss; Sarah M Buchanan; Heidi Murray-Smith; David M Cash; Ian B Malone; Carole H Sudre; William Coath; Andrew Wong; Susie M D Henley; Nick C Fox; Marcus Richards; Jonathan M Schott; Sebastian J Crutch Journal: Nat Aging Date: 2021-10-07
Authors: Ralph N Martins; Victor Villemagne; Hamid R Sohrabi; Pratishtha Chatterjee; Tejal M Shah; Giuseppe Verdile; Paul Fraser; Kevin Taddei; Veer B Gupta; Stephanie R Rainey-Smith; Eugene Hone; Steve Pedrini; Wei Ling Lim; Ian Martins; Shaun Frost; Sunil Gupta; Sid O'Bryant; Alan Rembach; David Ames; Kathryn Ellis; Stephanie J Fuller; Belinda Brown; Samantha L Gardener; Binosha Fernando; Prashant Bharadwaj; Samantha Burnham; Simon M Laws; Anna M Barron; Kathryn Goozee; Eka J Wahjoepramono; Prita R Asih; James D Doecke; Olivier Salvado; Ashley I Bush; Christopher C Rowe; Samuel E Gandy; Colin L Masters Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Isabelle Bos; Stephanie J B Vos; Willemijn J Jansen; Rik Vandenberghe; Silvy Gabel; Ainara Estanga; Mirian Ecay-Torres; Jori Tomassen; Anouk den Braber; Alberto Lleó; Isabel Sala; Anders Wallin; Petronella Kettunen; José L Molinuevo; Lorena Rami; Gaël Chetelat; Vincent de la Sayette; Magda Tsolaki; Yvonne Freund-Levi; Peter Johannsen; Gerald P Novak; Inez Ramakers; Frans R Verhey; Pieter Jelle Visser Journal: Front Aging Neurosci Date: 2018-06-25 Impact factor: 5.750
Authors: Christopher Fowler; Stephanie R Rainey-Smith; Sabine Bird; Julia Bomke; Pierrick Bourgeat; Belinda M Brown; Samantha C Burnham; Ashley I Bush; Carolyn Chadunow; Steven Collins; James Doecke; Vincent Doré; Kathryn A Ellis; Lis Evered; Amir Fazlollahi; Jurgen Fripp; Samantha L Gardener; Simon Gibson; Robert Grenfell; Elise Harrison; Richard Head; Liang Jin; Adrian Kamer; Fiona Lamb; Nicola T Lautenschlager; Simon M Laws; Qiao-Xin Li; Lucy Lim; Yen Ying Lim; Andrea Louey; S Lance Macaulay; Lucy Mackintosh; Ralph N Martins; Paul Maruff; Colin L Masters; Simon McBride; Lidija Milicic; Madeline Peretti; Kelly Pertile; Tenielle Porter; Morgan Radler; Alan Rembach; Joanne Robertson; Mark Rodrigues; Christopher C Rowe; Rebecca Rumble; Olivier Salvado; Greg Savage; Brendan Silbert; Magdalene Soh; Hamid R Sohrabi; Kevin Taddei; Tania Taddei; Christine Thai; Brett Trounson; Regan Tyrrell; Michael Vacher; Shiji Varghese; Victor L Villemagne; Michael Weinborn; Michael Woodward; Ying Xia; David Ames Journal: J Alzheimers Dis Rep Date: 2021-06-03
Authors: Lezanne Ooi; Mirella Dottori; Anthony L Cook; Martin Engel; Vini Gautam; Alexandra Grubman; Damián Hernández; Anna E King; Simon Maksour; Helena Targa Dias Anastacio; Rachelle Balez; Alice Pébay; Colin Pouton; Michael Valenzuela; Anthony White; Robert Williamson Journal: Neuroscientist Date: 2020-04-13 Impact factor: 7.519